Sprague Randy S, Olearczyk Jeffrey J, Spence Dana M, Stephenson Alan H, Sprung Robert W, Lonigro Andrew J
Department of Pharmacological and Physiological Science, School of Medicine, Saint Louis University, 1402 South Grand Blvd., St. Louis, MO 63104, USA.
Am J Physiol Heart Circ Physiol. 2003 Aug;285(2):H693-700. doi: 10.1152/ajpheart.01026.2002. Epub 2003 Apr 10.
Previously, it was reported that red blood cells (RBCs) are required to demonstrate participation of nitric oxide (NO) in the regulation of rabbit pulmonary vascular resistance (PVR). RBCs do not synthesize NO; hence, we postulated that ATP, present in millimolar amounts in RBCs, was the mediator, which evoked NO synthesis in the vascular endothelium. First, we found that deformation of RBCs, as occurs on passage across the pulmonary circulation with increasing flow rate, evoked increments in ATP release. Here, ATP (300 nM), administered to isolated, salt solution-perfused (PSS) rabbit lungs, decreased total and upstream (arterial) PVR, a response inhibited by NG-nitro-L-arginine methyl ester (L-NAME, 100 microM). In lungs perfused with PSS containing RBCs, L-NAME increased total and upstream PVR. In lungs perfused with PSS containing glibenclamide-treated RBCs, which inhibits ATP release, L-NAME was without effect. Apyrase grade VII (8 U/ml), which degrades ATP to AMP, was without effect on PVR in PSS-perfused lungs. These results are consistent with the hypothesis that ATP, released from RBCs as they traverse the pulmonary circulation, evokes endogenous NO synthesis.
此前有报道称,需要红细胞(RBCs)来证明一氧化氮(NO)参与调节兔肺血管阻力(PVR)。红细胞不合成NO;因此,我们推测红细胞中以毫摩尔量存在的ATP是介质,它能诱发血管内皮细胞合成NO。首先,我们发现红细胞的变形,如在肺循环中随着流速增加而发生的那样,会导致ATP释放增加。在这里,将ATP(300 nM)施用于分离的、用盐溶液灌注(PSS)的兔肺,可降低总PVR和上游(动脉)PVR,这种反应被NG-硝基-L-精氨酸甲酯(L-NAME,100 microM)抑制。在用含有红细胞的PSS灌注的肺中,L-NAME增加了总PVR和上游PVR。在用含有格列本脲处理的红细胞(抑制ATP释放)的PSS灌注的肺中,L-NAME没有作用。VII级腺苷三磷酸双磷酸酶(8 U/ml)可将ATP降解为AMP,对PSS灌注的肺中的PVR没有影响。这些结果与以下假设一致:红细胞在通过肺循环时释放的ATP会诱发内源性NO合成。